The global pneumatic compression devices for lymphedema market is expected to reach US$ 2.54 billion by 2030, growing at a CAGR of 8.7% during the forecast period. The market growth is attributed to the increasing prevalence of lymphedema, rising awareness about pneumatic compression therapy, and growing demand for home-based treatment options.

The pneumatic compression devices for lymphedema market is a rapidly growing market, driven by the increasing prevalence of lymphedema and the growing awareness of pneumatic compression therapy as a safe and effective treatment option.

To Get the Sample Copy of Report Visit! https://absolutemarketresearch.com/Global-Pneumatic-Compression-Devices-for-Lymphedem-Market/2275/request-sample

Pneumatic compression devices are used to apply intermittent pneumatic compression to the affected limb, which helps to move excess lymph fluid and reduce swelling. They are typically used in conjunction with other lymphedema treatments, such as manual lymphatic drainage and compression garments.

Key Market Drivers:

• Increasing prevalence of lymphedema: Lymphedema is a chronic condition that causes swelling in the limbs due to a build-up of lymph fluid. It is estimated that over 250 million people worldwide suffer from lymphedema. The prevalence of lymphedema is increasing due to the rising incidence of cancer, obesity, and other chronic diseases.
• Rising awareness about pneumatic compression therapy: Pneumatic compression therapy is a non-invasive treatment that uses inflatable sleeves to apply pressure to the affected limb. This helps to move lymph fluid and reduce swelling. Pneumatic compression therapy is becoming increasingly popular as a safe and effective treatment for lymphedema.
• Growing demand for home-based treatment options: Pneumatic compression devices are now available for home use, which is making treatment more convenient and accessible for patients. This is driving the demand for pneumatic compression devices, especially among patients with chronic lymphedema.

Key Takeaways:

• The global pneumatic compression devices for lymphedema market is expected to reach US$ 2.54 billion by 2030, growing at a CAGR of 8.7% during the forecast period.
• The rising number of orthopedic surgeries and the rising geriatric population worldwide are the major factors driving the market growth.
• The North American region is expected to dominate the market during the forecast period, due to the high prevalence of lymphedema and the increasing awareness of pneumatic compression devices.
• The intermittent pneumatic compression (IPC) devices segment is expected to account for the largest share of the market during the forecast period, due to their wide range of applications and their effectiveness in treating lymphedema.

Regional Outlook:

• The North American region is expected to dominate the global pneumatic compression devices for lymphedema market during the forecast period, due to the high prevalence of lymphedema and the increasing awareness of pneumatic compression devices.
• The European region is expected to be the second-largest market for pneumatic compression devices for lymphedema, due to the presence of a large number of key players and the increasing demand for these devices from hospitals and clinics.
• The Asia Pacific region is expected to be the fastest-growing market for pneumatic compression devices for lymphedema, due to the rising prevalence of lymphedema and the increasing disposable incomes in the region.

Key Players:

The major players in the global pneumatic compression devices for lymphedema market include:

• AIROS Medical, Inc.
• Lypha Press
• NormaTec LLC
• JOBST
• DJO Global, Inc.
• Medela, Inc.
• Flowtron Healthcare
• Zimmer Biomet Holdings, Inc.
• BSN medical
• Medi USA, Inc.
• Juzo

Segmentation:

The global pneumatic compression devices for lymphedema market is segmented by type, application, and end user.

By type:

• Intermittent pneumatic compression (IPC) devices
• Sequential pneumatic compression (SPC) devices

By application:

• Lymphedema
• Deep vein thrombosis (DVT)
• Venous stasis ulcers
• Other

By end user:

• Hospitals and clinics
• Home healthcare
• Ambulatory surgical centers